PET-CT in Pregnancy: — Why It Is Almost Always Avoided

Contact your oncologist or the centre where the scan was done the same day. They will calculate the approximate radiation dose your baby received, based on how far along the pregnancy was at the time of the scan. In most accidental exposures early in pregnancy, the estimated dose is below the threshold associated with measurable increased risk — but that calculation needs to be done by a specialist, not assumed. You will also be referred to a maternal-fetal medicine specialist who can advise on monitoring for the rest of the pregnancy.

For many cancer types, MRI can provide the information needed to make staging and treatment decisions, and guidance from ESMO and ACOG supports its use in pregnancy when the clinical need is there. MRI without gadolinium contrast is generally considered safe at all stages of pregnancy. Whether it is sufficient for your specific cancer is a question your oncologist needs to answer — some cancers rely on metabolic information that only PET provides, and those cases require careful multidisciplinary discussion rather than a straightforward swap.

Not necessarily. Harm depends on the dose received, the stage of pregnancy, and which organ systems were developing at the time. A single PET-CT does not automatically mean a serious outcome for the baby, but it is a real exposure that needs to be quantified by a specialist — not dismissed, and not assumed to be catastrophic. The risk assessment belongs with a maternal-fetal medicine specialist who can calculate what your specific exposure means for your pregnancy.

Yes, but with a short precaution. The radioactive tracer is excreted in breast milk for a period after the scan, and guidelines generally advise pausing breastfeeding for a set number of hours so the baby is not exposed through feeding. The centre will tell you exactly how long to pause before your scan. This is not a contraindication — it is a manageable precaution, and it does not affect the timing of your scan itself.

That depends on your cancer type, how quickly it is growing, and how urgently the staging information is needed to make a treatment decision. Your oncologist is the only person who can weigh that honestly for your situation. In many cases, starting treatment on the basis of MRI staging — while avoiding fetal radiation exposure — is clinically acceptable. In others, the delay would matter. Ask your oncologist directly what the clinical cost of the delay is for your specific cancer, rather than assuming either way.

The decision is made by a multidisciplinary team, not by your oncologist alone or by the imaging centre. It typically involves your oncologist, a radiologist with expertise in radiation protection, and a maternal-fetal medicine specialist. In some centres a medical physicist is also involved to calculate the projected fetal dose. At CION, if this situation arises, your referring doctor and the oncology team coordinate that discussion. The decision is explained to you clearly, and it is yours to accept or decline.